Use of c-myb antisense oligonucleotides to increase the sensitivity of human colon cancer cells to cisplatin

Oncology Reports

Volumn 8, Issue 4, 2001, Pages 807-810

  Funato, Tadao ^a  

^a TOHOKU UNIVERSITY   (Japan)

Author keywords

Antisense oligonucleotides; c myb; Cisplatin; Colon cancer; Drug resistance

Indexed keywords

ANTINEOPLASTIC AGENT; ANTISENSE OLIGONUCLEOTIDE; CISPLATIN; MESSENGER RNA; PROTEIN C MYB; RNA;

ADENOCARCINOMA; ARTICLE; BIOSYNTHESIS; CELL CULTURE; CELL DIVISION; COLON TUMOR; DRUG EFFECT; DRUG POTENTIATION; DRUG RESISTANCE; GENETICS; HUMAN; ONCOGENE MYB; POLYMERASE CHAIN REACTION;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; CELL DIVISION; CISPLATIN; COLONIC NEOPLASMS; DRUG RESISTANCE, NEOPLASM; DRUG SYNERGISM; GENES, MYB; HUMANS; OLIGONUCLEOTIDES, ANTISENSE; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS C-MYB; RNA, MESSENGER; RNA, NEOPLASM; TUMOR CELLS, CULTURED;

EID: 0035406511     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.8.4.807     Document Type: Article

References (2)

1. Sumner R, Crawford A, Mucenski M and Frampton J: Initiation of adult myelopoiesis can occur in the absence of c-myb whereas subsequent development is strictly dependent on the transcription factor. Oncogene 19: 3335-3342, 2000.
2. Weston K: Reassessing the role of C-MYB in tumorigenesis. Oncogene IS: 3034-3038, 1999.